| Tesoro Gold Ltd (TSO) ORDINARY FULLY PAID |
Materials |
$168 |
Wide Gold Intercepts at Ternera
|
30 Jun 2025 8:43AM |
$0.028 |
$0.940 |
risen by
3,257.14%
|
|
TSO - Price-sensitive ASX Announcement
Full Release
Key Points
- Tesoro Gold Ltd reported wide gold intercepts at the Ternera deposit.
- Drilling results confirm broad, consistent gold mineralization zones.
- Significant gold intervals were encountered in recent drill holes.
- The results support resource growth potential at the Ternera deposit.
- Gold mineralization continuity is demonstrated by the intercepts.
- The drilling results contribute to the project’s development and resource expansion.
- The Ternera deposit is part of the El Zorro Gold Project in Chile.
- These results are expected to enhance the company’s project advancement plans.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Yowie Group Ltd (YOW) ORDINARY FULLY PAID |
Consumer Staple |
$3 |
Results of Yowie s.249F Meeting
|
30 Jun 2025 8:42AM |
$0.014 |
$0.014 |
fallen by
0%
|
|
| King River Resources Limited (KRR) ORDINARY FULLY PAID |
Materials |
$81 |
Update - Notification of buy-back - KRR
|
30 Jun 2025 8:40AM |
$0.008 |
$0.055 |
risen by
587.50%
|
|
| Lodestar Minerals Limited (LSR) ORDINARY FULLY PAID |
Materials |
$15 |
Proposed issue of securities - LSR
|
30 Jun 2025 8:40AM |
$0.006 |
$0.010 |
risen by
66.67%
|
|
| Lodestar Minerals Limited (LSR) ORDINARY FULLY PAID |
Materials |
$15 |
Proposed issue of securities - LSR
|
30 Jun 2025 8:40AM |
$0.006 |
$0.010 |
risen by
66.67%
|
|
| Lodestar Minerals Limited (LSR) ORDINARY FULLY PAID |
Materials |
$15 |
Proposed issue of securities - LSR
|
30 Jun 2025 8:40AM |
$0.006 |
$0.010 |
risen by
66.67%
|
|
| Lodestar Minerals Limited (LSR) ORDINARY FULLY PAID |
Materials |
$15 |
Proposed issue of securities - LSR
|
30 Jun 2025 8:40AM |
$0.006 |
$0.010 |
risen by
66.67%
|
|
| Lodestar Minerals Limited (LSR) ORDINARY FULLY PAID |
Materials |
$15 |
Proposed issue of securities - LSR
|
30 Jun 2025 8:39AM |
$0.006 |
$0.010 |
risen by
66.67%
|
|
| Lodestar Minerals Limited (LSR) ORDINARY FULLY PAID |
Materials |
$15 |
Capital raising
|
30 Jun 2025 8:39AM |
$0.006 |
$0.010 |
risen by
66.67%
|
|
LSR - Price-sensitive ASX Announcement
Full Release
Key Points
- Lodestar Minerals Limited is raising capital through a placement and entitlement offer.
- Up to $2,700,000 is targeted to be raised before costs.
- Placement shares are offered at $0.007 per share to sophisticated and professional investors.
- Entitlement offer is a non-renounceable pro-rata issue to eligible shareholders.
- Funds will be allocated to exploration, working capital, and offer expenses.
- The document outlines the timetable, eligibility criteria, and terms of the capital raising.
- Risks associated with the capital raising are discussed.
- Details about how to participate and eligibility requirements are included.
- Directors and related parties’ potential participation is disclosed.
- Purpose of the capital raising is to drive the company’s exploration and development objectives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Complii Fintech Solutions Ltd (CF1) ORDINARY FULLY PAID |
Information Technology |
$17 |
Change of director's interest notice
|
30 Jun 2025 8:39AM |
$0.021 |
$0.028 |
risen by
33.33%
|
|
| Barton Gold Holdings Limited (BGD) ORDINARY FULLY PAID |
Materials |
$204 |
'Stage 1' Resources at Central Gawler Mill Grow to 223koz Au
|
30 Jun 2025 8:38AM |
$0.795 |
$0.755 |
fallen by
5.03%
|
|
BGD - Price-sensitive ASX Announcement
Full Release
Key Points
- Barton Gold Holdings has increased Central Gawler Mill 'Stage 1' gold resources to 223,000 ounces.
- The resource update follows recent drilling and resource estimation efforts.
- Resources are presented by location and classification: Measured, Indicated, and Inferred.
- The update supports Barton's near-term plans to develop and process gold resources.
- Technical programs and drilling are ongoing to further expand and upgrade resources.
- The announcement highlights strategic steps in advancing gold production in South Australia.
- Barton Gold aims to leverage its assets for enhanced shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vitasora Health Limited (VHL) ORDINARY FULLY PAID |
Health Care |
$26 |
Vitasora Secures Value-Based Partnership
|
30 Jun 2025 8:38AM |
$0.039 |
$0.011 |
fallen by
71.79%
|
|
VHL - Price-sensitive ASX Announcement
Full Release
Key Points
- Vitasora Health Limited has entered into a value-based partnership with a leading healthcare provider.
- The partnership aims to improve patient outcomes and reduce healthcare costs.
- Focus areas include innovative care delivery models and data-driven solutions.
- Both parties will align incentives to prioritize quality care and patient satisfaction.
- Advanced technologies will be used to monitor and track clinical outcomes.
- The collaboration underscores VHL's commitment to healthcare transformation.
- Measurable outcomes and operational efficiencies are central to the partnership's strategy.
- The announcement was made on May 9, 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rox Resources Limited (RXL) ORDINARY FULLY PAID |
Materials |
$542 |
Application for quotation of securities - RXL
|
30 Jun 2025 8:36AM |
$0.290 |
$0.390 |
risen by
34.48%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,926 |
Net Tangible Asset Backing
|
30 Jun 2025 8:36AM |
$2.930 |
$4.610 |
risen by
57.34%
|
|
| New World Resources Limited (NWC) ORDINARY FULLY PAID |
Materials |
- |
Transaction Update
|
30 Jun 2025 8:35AM |
$0.065 |
$0.067 |
risen by
3.08%
|
|
NWC - Price-sensitive ASX Announcement
Full Release
Key Points
- New World Resources Limited released an update concerning its acquisition of the Antler Copper Project in Arizona.
- The company continues to advance the transaction, focusing on due diligence and regulatory compliance.
- NWC highlighted the strategic value of the Antler Project to its asset portfolio.
- The transaction is expected to deliver long-term shareholder value and support growth within the copper sector.
- Steps toward completion of the transaction were detailed, including expected timelines and next actions.
- The company emphasized its commitment to transparency and keeping shareholders informed throughout the process.
- NWC remains focused on ensuring that all aspects of the acquisition meet regulatory and governance standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Noble Helium Limited (NHE) ORDINARY FULLY PAID |
Energy |
$32 |
Loan Facility
|
30 Jun 2025 8:35AM |
$0.024 |
$0.026 |
risen by
8.33%
|
|
NHE - Price-sensitive ASX Announcement
Full Release
Key Points
- Noble Helium Limited has entered into a loan facility agreement.
- The facility will provide additional working capital for ongoing operations.
- Funds will support the North Rukwa Helium Project in Tanzania.
- Key terms and security arrangements of the loan are outlined in the announcement.
- The rationale for the loan is to strengthen financial position and progress strategic objectives.
- The announcement details the expected impact of the facility on company operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Morphic Ethical Equities Fund Limited (MEC) ORDINARY FULLY PAID |
Financials |
$41 |
Update - Notification of buy-back - MEC
|
30 Jun 2025 8:35AM |
$1.090 |
$1.360 |
risen by
24.77%
|
|
| Emerald Resources NL (EMR) ORDINARY FULLY PAID |
Materials |
$3,720 |
Exploration and Resource Drilling Update
|
30 Jun 2025 8:34AM |
$3.890 |
$5.630 |
risen by
44.73%
|
|
| Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$69 |
Update - Notification of buy-back - M7T
|
30 Jun 2025 8:34AM |
$0.345 |
$0.295 |
fallen by
14.49%
|
|
| Electro Optic Systems Holdings Limited (EOS) ORDINARY FULLY PAID |
Industrials |
$2,046 |
1H Trading Update
|
30 Jun 2025 8:33AM |
$2.710 |
$9.440 |
risen by
248.34%
|
|
EOS - Price-sensitive ASX Announcement
Full Release
Key Points
- EOS released its 1H FY2024 Trading Update, highlighting strong revenue and EBITDA growth.
- Unaudited revenue for 1H FY2024 is expected to exceed $170 million, up more than 85% from the prior corresponding period.
- Underlying EBITDA for 1H FY2024 is expected to be over $17 million, a significant turnaround from a $4 million loss in 1H FY2023.
- EOS secured major contracts and order intake, including a $150 million contract with a significant international customer and a $51 million contract with the Australian Defence Force.
- The company reported a robust order backlog and pipeline, providing revenue visibility into FY2025 and beyond.
- Business restructuring and cost management initiatives implemented in prior periods contributed to improved margins and profitability.
- EOS is focusing on core Defence and Space market segments, with growing global demand for its Remote Weapon Systems, Counter-UAS, and Space Communications solutions.
- The company maintains a strong balance sheet with improved net cash position and reduced debt.
- EOS confirmed its FY2024 guidance, expecting revenues of $350–$370 million and positive underlying EBITDA for the full year.
- The company continues to invest in R&D to support future growth and sustain its technology leadership.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Metal Powder Works Limited (MPW) ORDINARY FULLY PAID |
Industrials |
$224 |
MPW Delivers Two Strategic Operational Milestones
|
30 Jun 2025 8:33AM |
$1.760 |
$1.850 |
risen by
5.11%
|
|
MPW - Price-sensitive ASX Announcement
Full Release
Key Points
- MPW commissioned its first commercial powder production cell in the UK.
- The company received a significant commercial order for metal powder from a major global customer.
- The milestones validate MPW’s proprietary technology for producing sustainable and efficient metal powders.
- These achievements prove MPW’s capability to scale production to commercial levels.
- The order and operational readiness strengthen MPW’s relationships with global industrial partners.
- MPW’s strategy focuses on sustainable, high-quality powder solutions for additive manufacturing and industrial sectors.
- The company is on track with its strategic growth and commercialization plans.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dimerix Limited (DXB) ORDINARY FULLY PAID |
Health Care |
$114 |
Dimerix receives 1st Development Milestone payment from FUSO
|
30 Jun 2025 8:33AM |
$0.570 |
$0.190 |
fallen by
66.67%
|
|
DXB - Price-sensitive ASX Announcement
Full Release
Key Points
- Dimerix Limited (ASX: DXB) announced the receipt of its first development milestone payment from FUSO Pharmaceutical Industries under their exclusive license agreement for DMX-200 in Japan.
- The milestone payment was triggered by the completion of the first patient visit in the ACTION3 pivotal Phase 3 clinical study for DMX-200, a potential therapy for focal segmental glomerulosclerosis (FSGS).
- FUSO has exclusive rights to commercialize DMX-200 for FSGS in Japan, with Dimerix eligible for further development, regulatory, and sales milestones, as well as royalties on net sales.
- DMX-200 is being evaluated in a global Phase 3 clinical trial for FSGS, a rare kidney disease with limited treatment options.
- The milestone payment strengthens Dimerix's cash position and supports ongoing clinical development activities.
- The ACTION3 study is enrolling patients globally, including in Japan, and Dimerix expects further regulatory submissions and milestones as the trial progresses.
- Dimerix retains global rights to DMX-200 outside of Japan and continues to seek additional partnerships and licensing opportunities.
- The company emphasizes its commitment to developing novel therapies for patients with unmet medical needs in kidney disease.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ariadne Australia Limited (ARA) ORDINARY FULLY PAID |
Industrials |
$90 |
Update - Notification of buy-back - ARA
|
30 Jun 2025 8:32AM |
$0.470 |
$0.470 |
fallen by
0%
|
|
| Butn Limited (BTN) ORDINARY FULLY PAID |
Financials |
$6 |
Proposed issue of securities - BTN
|
30 Jun 2025 8:32AM |
$0.110 |
$0.015 |
fallen by
86.36%
|
|
| Hearts and Minds Investments Limited (HM1) ORDINARY FULLY PAID |
Financials |
$655 |
Weekly NTA Estimate
|
30 Jun 2025 8:32AM |
$3.010 |
$2.860 |
fallen by
4.98%
|
|
Call 1300 880 160
Start a chat
Schedule a call
